COVID-19 drug development based on boosting immunity 6SHARES Share via Pinterest Reddit Buffer Xing WhatsApp Flipboard Posted: 31 December 2020 | Baidyanath Dash (G3 Systems) | No comments yet Baidyanath Dash explains the two requirements for COVID-19 drug development: killing the virus and boosting immunity. Click here to read the article. With regular news updates and feature articles, our COVID-19 hub has everything you need to keep up to date with R&D during the pandemic. Click below to visit: COVID-19 hub Related topicsDisease research, Drug Development, Drug Targets, Research & Development, Targets Related conditionsCovid-19